Hepatocellular carcinoma after a sustained virological response by direct‐acting antivirals harbors TP53 inactivation

INTRODUCTION: The genomic characteristics of hepatocellular carcinoma (HCC) after a sustained virological response (SVR) and its differences according to whether an SVR was achieved by treatment with direct‐acting antivirals (DAA) or interferon (IFN) are still not fully understood. METHODS: Sixty‐ni...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Taisuke, Okamura, Yukiyasu, Ohshima, Keiichi, Uesaka, Katsuhiko, Sugiura, Teiichi, Ito, Takaaki, Yamamoto, Yusuke, Ashida, Ryo, Ohgi, Katsuhisa, Otsuka, Shimpei, Ohnami, Sumiko, Nagashima, Takeshi, Hatakeyama, Keiichi, Kakuda, Yuko, Sugino, Takashi, Urakami, Kenichi, Akiyama, Yasuto, Yamaguchi, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041076/
https://www.ncbi.nlm.nih.gov/pubmed/35174643
http://dx.doi.org/10.1002/cam4.4571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041076/
https://www.ncbi.nlm.nih.gov/pubmed/35174643
http://dx.doi.org/10.1002/cam4.4571

Ejemplares similares